AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,090.00p
   
  • Change Today:
    -98.00p
  • 52 Week High: 12,712.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.69m
  • Volume: 1,824,441
  • Market Cap: £187,479m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
14-Aug-25 Sell Aradhana Sarin 11,511.70p 9,563 £1,100,863.84

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-Aug-25 Sell Aradhana Sarin 11,511.70p 9,563 £1,100,863.84

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £106,741,522
Aradhana Sarin 108,804 £13,154,404
Marcus Wallenberg 60,028 £7,257,385
Michel Demare 10,000 £1,209,000
Philip A J Broadley 8,025 £970,222
Tony Mok 3,500 £423,150
Sheri McCoy 1,736 £209,882
Diana Layfield 1,400 £169,260
Karen Knudsen 1,400 £169,260
Euan Ashley 1,150 £139,035
Nazneen Rahman 1,017 £122,955
Anna Manz 487 £58,878

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £12,197,018,383
Oddo Meriten Asset Management SA 100,885,181 £12,197,018,383
The Capital Group Companies, Inc. 77,684,561 £9,392,063,425
Wellington Management Company LLP 65,118,411 £7,872,815,890
Investor AB 51,587,810 £6,236,966,229

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,090.00p
Change Today -98.00p
% Change -0.80 %
52 Week High 12,712.00p
52 Week Low 9,667.00p
Volume 1,824,441
Shares Issued 1,550.69m
Market Cap £187,479m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 05-Sep-2025

Time Volume / Share Price
16:05 0 @ 12,124.00p
16:05 2 @ 12,124.00p
16:05 0 @ 12,124.00p
15:57 0 @ 12,102.00p
15:59 2 @ 12,092.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page